Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Pulmonary arterial hypertension in SLE: what do we know?
A Prabu
, C Gordon
Immunology and Immunotherapy
Research output
:
Contribution to journal
›
Article
›
peer-review
18
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pulmonary arterial hypertension in SLE: what do we know?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Systemic Lupus Erythematosus
100%
Pulmonary Hypertension
100%
Pulmonary Arterial Hypertension
100%
Lupus
11%
Common Cause
11%
Immunosuppression
11%
Disease-associated
11%
Antiphospholipid Antibodies
11%
Hypertension Diagnosis
11%
Systemic Sclerosis
11%
Hypertension Management
11%
Echocardiographic Evaluation
11%
Early Diagnosis
11%
Connective Tissue Disease
11%
Lupus Low Disease Activity State (LLDAS)
11%
Right Heart
11%
False Positive Rate
11%
Pulmonary Artery Systolic Pressure
11%
Pressure Estimation
11%
Prompt Treatment
11%
Fatal Outcome
11%
Idiopathic Pulmonary Arterial Hypertension
11%
Medicine and Dentistry
Pulmonary Hypertension
100%
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
11%
Awareness
5%
Immunosuppressive Treatment
5%
Disease Activity
5%
Antiphospholipid Antibody
5%
Systemic Scleroderma
5%
Lung Artery Pressure
5%
Connective Tissue Disease
5%
Early Diagnosis
5%
False Positive Result
5%
Fatality
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
Systemic Lupus Erythematosus
100%
Disease Activity
5%
Systemic Sclerosis
5%
Fatality
5%
Antiphospholipid Antibody
5%
Connective Tissue Disease
5%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Lupus Erythematosus
25%
Awareness
12%
Immunosuppression
12%
Phospholipid Antibody
12%
Systemic Scleroderma
12%
Connective Tissue
12%
Lung Artery Pressure
12%